echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Pfizer/BioNTech's new crown vaccine for 5-11 years old children obtains FDA emergency use authorization

    Pfizer/BioNTech's new crown vaccine for 5-11 years old children obtains FDA emergency use authorization

    • Last Update: 2021-11-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Article source: Medical Rubik's Cube Info

    Author: Sunshine

    Recently, Pfizer and BioNTech announced that the COVID-19 vaccine Comirnaty (tozinameran, BNT162b2) for use in children aged 5-11 has received an emergency use authorization (EUA) from the FDA
    .


    For this age group, the dosage regimen is: a dose of 10 µg, with a second injection at 21 days intervals


    The FDA's decision is based on data from a Phase II/III clinical trial
    .


    A total of 4,500 children aged 5-11 years were enrolled in the study


    Pfizer and BioNTech have submitted authorization requests for the COVID-19 vaccine for this age group to global regulatory agencies such as the European Medicines Agency
    .


    At present, there are two clinical trials of Comirnaty for children (2-5 years old, 6 months-2 years old) are underway, and initial data will be released in the fourth quarter of 2021 or the first quarter of 2022 at the earliest


    Note: The original text has been deleted

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.